NDC 0536-1333 – Guaifenesin D
Guaifenesin 600 mg/1; Pseudoephedrine Hydrochloride 60 mg/1 · Tablet, Extended Release · Oral
Product NDC0536-1333
Product details
- Brand name
- Guaifenesin D
- Generic name
- Guaifenesin and Pseudoephedrine Hydrochloride
- Labeler
- RUGBY LABORATORIES, INC.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA212542
- Marketed since
- April 4, 2022
- Marketing end
- March 31, 2027
- Pharmacologic class
- Expectorant; alpha-Adrenergic Agonist
Active ingredients
- Guaifenesin 600 mg/1
- Pseudoephedrine Hydrochloride 60 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0536-1333-21 | 1 BLISTER PACK in 1 CARTON (0536-1333-21) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Apr 4, 2022 |
| 0536-1333-36 | 2 BLISTER PACK in 1 CARTON (0536-1333-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Apr 4, 2022 |